An increased level of IL12p70 and IFN-γ, decreased levels of immunosuppressive IL-10 and IL-4, and elevated T-lymphocyte infiltration in tumor tissues in TEXomiR-treated mice do suggest that TEXomiR treatment elicits strong immunomodulatory effects. Here, IFNG is linked to neoplasm.